Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. (RYTM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RYTM · as of Jun 8, 2026
Key Statistics
Explore Rhythm Pharmaceuticals, Inc. Data
rytm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 20 · Buy rate: 100.0%
The RYTM analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month price target is $140.20, representing +63.17% upside from the current price of $85.92.
Competitors & Peers
rytm competitorsRYTM
ACLX
AKRO
ARVN
BDTX
CGEMStock Performance
Full HistoryAbout Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that ca…
what is rhythm pharmaceuticals, inc. · rytm stock overview · rhythm pharmaceuticals, inc. company profile · who is rhythm pharmaceuticals, inc. ceo · rytm NASDAQ · rhythm pharmaceuticals, inc. headquarters · rhythm pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Rhythm Pharmaceuticals, Inc. (RYTM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 9, 2017. As of the latest trading session, RYTM stock price is $85.92, with a market capitalization of $5.9B. The stock has returned +28.78% over the past 12 months and -19.73% year-to-date.
According to 20 Wall Street analysts, the consensus rating for Rhythm Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $140.20. In fiscal year 2025, Rhythm Pharmaceuticals, Inc. reported revenue of $189.8M and net income of -$196.5M. For detailed data — including Rhythm Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Rhythm Pharmaceuticals, Inc. (RYTM) stock price is $85.92. The stock is traded on NASDAQ under the ticker symbol RYTM. The 52-week range is $60.70 – $122.20.